{"id":"NCT00109343","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)","officialTitle":"An Open, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of V221 Given Concomitantly With Pneumococcal Conjugate Vaccine in Healthy Children 12 to 15 Months of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-03","primaryCompletion":"2007-09","completion":"2007-09","firstPosted":"2005-04-27","resultsPosted":"2010-02-10","lastUpdate":"2017-04-12"},"enrollment":1027,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Measles","Mumps","Rubella","Varicella"],"interventions":[{"type":"BIOLOGICAL","name":"Comparator: ProQuad™ (V221)","otherNames":["ProQuad™","V221"]},{"type":"BIOLOGICAL","name":"Comparator: PREVNAR™ (pneumococcal 7-valent conjugate vaccine)","otherNames":["PREVNAR™"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"EXPERIMENTAL"}],"summary":"The study is being conducted to demonstrate that V221 may be administered concomitantly with pneumococcal conjugate vaccine without impairing the safety or immunogenicity of measles, mumps, rubella, varicella, or the 7 serotypes of S. pneumoniae.","primaryOutcome":{"measure":"Number of Participants With Postvaccination Measles Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titer ≥255 mIU/mL","timeFrame":"6 weeks Postvaccination in subjects receiving ProQuad™ concomitantly with a fourth dose of Prevnar™ and in subjects receiving ProQuad™ alone","effectByArm":[{"arm":"Group 1 - ProQuad™ + PREVNAR™","deltaMin":395,"sd":null},{"arm":"Group 3 - ProQuad™ Followed by PREVNAR™","deltaMin":203,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22123890"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":498},"commonTop":["Injection Site Pain (ProQuad Injection-site)","Pyrexia","Injection Site Erythema (ProQuad Injection-site)","Injection Site Swelling (ProQuad Injection-site)","Upper Respiratory Tract Infection"]}}